ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 180 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $59,996 | -34.0% | 7,957 | -11.4% | 0.04% | -38.0% |
Q4 2022 | $90,927 | -38.6% | 8,976 | -13.1% | 0.07% | +86.8% |
Q4 2021 | $148,000 | -39.1% | 10,327 | -14.9% | 0.04% | -22.4% |
Q3 2021 | $243,000 | -61.2% | 12,142 | -57.4% | 0.05% | -50.5% |
Q2 2021 | $627,000 | -46.9% | 28,491 | -18.0% | 0.10% | -43.4% |
Q1 2021 | $1,180,000 | – | 34,761 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |